Who to call at RxMP Therapeutics, and when
Fundz watches for the moments RxMP Therapeutics starts buying, and tells you who to reach.
- An alert the day RxMP Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at RxMP Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at RxMP Therapeutics. With Fundz connected, it knows.
DARPA Awards Up to $10.7 Million Contract to RxMP Therapeutics for Development of RMP-402.
Contract Type
contract
MiamiBiotechnologyHealth CareTherapeuticsPharmaceuticalDescription
RxMP Therapeutics, Inc. has been awarded a contract of up to $10.7 million from DARPA to support the development and manufacturing scale-up of RMP-402. The funding is essential for completing preclinical and regulatory milestones necessary for the product's advancement toward clinical trials.
Quick answer
DARPA Awards Up to $10.7 Million Contract to RxMP Therapeutics for Development of RMP-402. (October 20, 2026). RxMP Therapeutics is based in Miami, Florida, United States.
- What agreement did RxMP Therapeutics announce on October 20, 2026?
- RxMP Therapeutics, Inc. has been awarded a contract of up to $10.7 million from DARPA to support the development and manufacturing scale-up of RMP-402. The funding is essential for completing preclinical and regulatory milestones necessary for the product's advancement toward clinical trials.
- What does RxMP Therapeutics do?
- RxMP Therapeutics is a pharmaceutical company focused on developing proprietary drugs for the management of excessive bleeding.
- Where is RxMP Therapeutics based?
- RxMP Therapeutics is based in Miami, Florida, United States.
- Which similar companies announced contracts around the same time?
- Alexion (October 29, 2026), AbbVie Inc. (November 3, 2026), Teva Pharmaceutical Industries Ltd (November 3, 2026) and Sino Biopharmaceutical (November 13, 2026) also announced agreements within 45 days of RxMP Therapeutics.
Source: Fundz verified event record.
Other recent agreements in Therapeutics and Pharmaceutical
Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.
- Wolves Foundation and Alexion extend partnership to support Wolves Disability FC and Wolves Wishes for three more years. (October 29, 2026)
- AbbVie partners with McLaren Racing in a multiyear collaboration to promote liver health awareness through Formula 1. (November 3, 2026)
- Teva and Samsung Bioepis Sign Agreement for U.S. Rights to Biosimilars Infliximab and Etanercept. (November 3, 2026)
- Sino Biopharmaceutical Partners with Boehringer Ingelheim in a $358 Million Oncology Deal (November 13, 2026)
- Pfizer Partners with Blackstone Life Sciences to Co-Fund $1.5 Billion Development for Berobenatide Obesity Drug. (November 14, 2026)
- Prothena Partners with Roche to Advance Prasinezumab for Parkinson's Disease Treatment. (October 20, 2026)
Related People
RxMP Therapeutics signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.